Table 3.
Clinicopathological characteristics of patients with cervical squamous cell carcinoma in relation to pelvic LNM (n = 296)
| Characteristics | Pelvic LNM negative, n (%) | Pelvic LNM positive, n (%) | P |
|---|---|---|---|
| Age | 0.28 | ||
| ≤35 years | 25 (89.3) | 3 (10.7) | |
| >35 years | 211 (78.7) | 57 (21.3) | |
| Gravidity | 0.79 | ||
| ≤2 | 95 (80.51) | 23 (19.49) | |
| >2 | 141 (79.21) | 37 (20.79) | |
| Clinical stage | 0.00 | ||
| IA | 33 (100) | 0 (0.00) | |
| IB | 118 (82.52) | 25 (17.48) | |
| IIA | 46 (75.41) | 15 (24.59) | |
| IIB | 39 (66.10) | 20 (33.90) | |
| Histological grade | 0.00 | ||
| G1 | 52 (96.30) | 2 (3.70) | |
| G2–G3 | 184 (76.03) | 58 (23.97) | |
| Tumor diameter (cm) | 0.01 | ||
| ≤4 | 187 (83.11) | 38 (16.89) | |
| >4 | 49 (69.01) | 22 (30.99) | |
| LVSI | 0.00 | ||
| Negative | 169 (90.86) | 17 (9.14) | |
| Positive | 67 (60.91) | 43 (39.09) | |
| The depth of cervical stromal invasion | 0.00 | ||
| <1/2 | 145 (92.95) | 11 (7.05) | |
| ≥1/2 | 91 (65.00) | 49 (35.00) | |
| Uterine invasion | 0.00 | ||
| Negative | 223 (83.21) | 45 (16.79) | |
| Positive | 13 (46.43) | 15 (53.57) | |
| Parametrial invasion | 0.00 | ||
| Negative | 234 (81.53) | 53 (18.47) | |
| Positive | 2 (22.22) | 7 (77.78) | |
| NACT | 0.02 | ||
| Yes | 79 (72.48) | 30 (27.52) | |
| No | 157 (83.96) | 30 (16.04) |
LVSI: Lymph-vascular space involvement; NACT: Neoadjuvant chemotherapy; LNM: Lymph node metastasis.